ArticleMolecular biotechnology2025
Pan-Cancer Analysis Shows that KIFC2 is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer.
Helin Zhang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.